Press Releases

CRANFORD, N.J., Feb. 10, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at Noble Capital Markets' 16th Annual Investor Conference on Monday, February

BELLEVUE, Wash., Feb. 10, 2020 /PRNewswire/ -- Awards for achievement in the contact lens field were presented recently to three team members of Innovega, a company engaged in developing stylish, li

CHICAGO, Feb. 10, 2020 /PRNewswire/ -- Charles J. Goodacre, DDS, MSD, FACP, was honored with the President's Award from the American College of Prosthodontists (ACP). This award recognizes outstanding vision and leadership within the ACP and the specialty of prosthodontics. He received the honor at the 49th Annual Session of the ACP held in

NEW YORK, Feb. 10, 2020 /PRNewswire/ -- NeuroRx will update investors at the upcoming BIO CEO conference on Monday, February 10, 2020 at 10:15am.  The company's CEO, Dr. Jonathan Javitt will be presenting an overview of recent results obtai

SAN DIEGO, Feb. 10, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable in

BOONTON, N.J., Feb. 10, 2020 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery tech

BRIDGEWATER, N.J., Feb. 10, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its fourth quarter and year-end financial results on Tuesday, February 25, 2020.Insm

MARLBOROUGH, Mass., Feb. 10, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced that it has received a letter from The Nasdaq Stock Market LLC advising the Company that it

ENCINITAS, Calif., Feb. 10, 2020 /PRNewswire/ -- mySugr, a digital health company committed to simplifying life for people with diabetes, announced its coaching program has been accredited by the American Association of Diabetes Educators (AADE). This prestigious accreditation status distinguishes mySugr as a leader in reinventing diabetes care and imp

AMSTERDAM, Feb. 10, 2020 /PRNewswire/ -- Evidentia Learning today announced a joint project with the International Centre for Missing & Exploited Children (ICMEC) to provide free access to high-quality accredited online training modules to healthcare professionals in low-income and lower-middle income countries (based on World Bank criteria). The comprehensive